Drug Development Pipeline
Ibuprofen is an oral, non-steroidal, anti-inflammatory medication.
A four-year high dose ibuprofen trial completed in 1994 demonstrated less lung function decline in the treatment group than the control group. The effect was more pronounced in people with CF who were younger than age 13 when they started the trial.
The program was funded by the Cystic Fibrosis Foundation.
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.Learn More